(Q42993950)

English

A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients

scientific article published in August 2005

Statements

A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients (English)
Gary L Davis
David R Nelson
Thomas D Schiano
Courtney V Fletcher
Christine V Sapan
Laura N Riser
Yufeng Li
Richard J Whitley
John W Gnann
Collaborative Antiviral Study Group
1 August 2005
941-949

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit